{"count": 31, "results": [{"_id": "33193076", "pmid": 33193076, "pmcid": "PMC7642096", "title": "Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus", "journal": "Front Endocrinol (Lausanne)", "authors": ["Tseng CH"], "date": "2020-10-22T00:00:00Z", "doi": "10.3389/fendo.2020.541090", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "541090", "score": 50260.098, "text_hl": "...The effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@ risk remains unknown.", "citations": {"NLM": "Tseng CH. Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus Front Endocrinol (Lausanne). 2020;11():541090. PMID: 33193076", "BibTeX": "@article{33193076, title={Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus}, author={Tseng CH}, journal={Front Endocrinol (Lausanne)}, volume={11}, pages={541090}}"}}, {"_id": "33747367", "pmid": 33747367, "pmcid": "PMC7967492", "title": "Metformin - its anti-cancer effects in hematologic malignancies", "journal": "Oncol Rev", "authors": ["Podhorecka M"], "date": "2021-02-26T00:00:00Z", "doi": "10.4081/oncol.2021.514", "meta_date_publication": "2021 Feb 26", "meta_volume": "15", "meta_issue": "1", "meta_pages": "514", "score": 50256.836, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in the therapy of different types of @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@", "citations": {"NLM": "Podhorecka M. Metformin - its anti-cancer effects in hematologic malignancies Oncol Rev. 2021 Feb 26;15(1):514. PMID: 33747367", "BibTeX": "@article{33747367, title={Metformin - its anti-cancer effects in hematologic malignancies}, author={Podhorecka M}, journal={Oncol Rev}, volume={15}, number={1}, pages={514}}"}}, {"_id": "32460059", "pmid": 32460059, "title": "Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase.", "journal": "Leuk Res", "authors": ["Saito T", "Itoh M", "Tohda S"], "date": "2020-07-01T00:00:00Z", "doi": "10.1016/j.leukres.2020.106383", "meta_date_publication": "2020 Jul", "meta_volume": "94", "meta_issue": "", "meta_pages": "106383", "score": 50255.27, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ suppresses the growth of @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@ cells partly through downregulation of @GENE_AXL @GENE_558 @@@AXL@@@ @GENE_RET @GENE_5979 @@@receptor tyrosine kinase@@@.", "citations": {"NLM": "Saito T, Itoh M, Tohda S. Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase. Leuk Res. 2020 Jul;94():106383. PMID: 32460059", "BibTeX": "@article{32460059, title={Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase.}, author={Saito T and Itoh M and Tohda S}, journal={Leuk Res}, volume={94}, pages={106383}}"}}, {"_id": "35079096", "pmid": 35079096, "pmcid": "PMC8789909", "title": "Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)", "journal": "Sci Rep", "authors": ["Allende-Vega N", "Marco Brualla J", "Falvo P", "Alexia C", "Constantinides M", "de Maudave AF", "Coenon L", "Gitenay D", "Mitola G", "Massa P", "Orecchioni S", "Bertolini F", "Marzo I", "Anel A", "Villalba M"], "date": "2022-01-25T00:00:00Z", "doi": "10.1038/s41598-022-05470-x", "meta_date_publication": "2022 Jan 25", "meta_volume": "12", "meta_issue": "1", "meta_pages": "1341", "score": 50253.17, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ sensitizes @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemic@@@ cells to NK cells. ", "citations": {"NLM": "Allende-Vega N, Marco Brualla J, Falvo P, Alexia C, Constantinides M, de Maudave AF, Coenon L, Gitenay D, Mitola G, Massa P, Orecchioni S, Bertolini F, Marzo I, Anel A, Villalba M. Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1) Sci Rep. 2022 Jan 25;12(1):1341. PMID: 35079096", "BibTeX": "@article{35079096, title={Metformin sensitizes leukemic cells to cytotoxic lymphocytes by increasing expression of intercellular adhesion molecule-1 (ICAM-1)}, author={Allende-Vega N and Marco Brualla J and Falvo P and Alexia C and Constantinides M and de Maudave AF and Coenon L and Gitenay D and Mitola G and Massa P and Orecchioni S and Bertolini F and Marzo I and Anel A and Villalba M}, journal={Sci Rep}, volume={12}, number={1}, pages={1341}}"}}, {"_id": "37364455", "pmid": 37364455, "title": "Repurposing Metformin in hematologic tumor: State of art.", "journal": "Curr Probl Cancer", "authors": ["Hu M", "Chen Y", "Ma T", "Jing L"], "date": "2023-06-20T00:00:00Z", "doi": "10.1016/j.currproblcancer.2023.100972", "meta_date_publication": "2023 Jun 20", "meta_volume": "47", "meta_issue": "4", "meta_pages": "100972", "score": 50250.09, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ also plays an important role in the treatment of @DISEASE_Hematologic_Neoplasms @DISEASE_MESH:D019337 @@@hematologic tumors@@@, especially in @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@, @DISEASE_Lymphoma @DISEASE_MESH:D008223 @@@lymphoma@@@, and @DISEASE_Multiple_Myeloma @DISEASE_MESH:D009101 @@@multiple myeloma@@@ (@DISEASE_Multiple_Myeloma @DISEASE_MESH:D009101 @@@MM@@@). ", "citations": {"NLM": "Hu M, Chen Y, Ma T, Jing L. Repurposing Metformin in hematologic tumor: State of art. Curr Probl Cancer. 2023 Jun 20;47(4):100972. PMID: 37364455", "BibTeX": "@article{37364455, title={Repurposing Metformin in hematologic tumor: State of art.}, author={Hu M and Chen Y and Ma T and Jing L}, journal={Curr Probl Cancer}, volume={47}, number={4}, pages={100972}}"}}, {"_id": "39585587", "pmid": 39585587, "title": "Molecular Secrets Revealed: How Diabetes may be Paving the Way for Leukemia.", "journal": "Curr Treat Options Oncol", "authors": ["Goleij P", "Khazeei Tabari MA", "Ahmed ARD", "Mohamed LME", "Saleh GAH", "Abdu Hassan MTM", "Moahmmednoor AGM", "Khan H"], "date": "2024-11-25T00:00:00Z", "doi": "10.1007/s11864-024-01281-6", "meta_date_publication": "2024 Nov 25", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50248.543, "text_hl": "Molecular Secrets Revealed: How @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ may be Paving the Way for @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@Leukemia@@@.", "citations": {"NLM": "Goleij P, Khazeei Tabari MA, Ahmed ARD, Mohamed LME, Saleh GAH, Abdu Hassan MTM, Moahmmednoor AGM, Khan H. Molecular Secrets Revealed: How Diabetes may be Paving the Way for Leukemia. Curr Treat Options Oncol. 2024 Nov 25;():. PMID: 39585587", "BibTeX": "@article{39585587, title={Molecular Secrets Revealed: How Diabetes may be Paving the Way for Leukemia.}, author={Goleij P and Khazeei Tabari MA and Ahmed ARD and Mohamed LME and Saleh GAH and Abdu Hassan MTM and Moahmmednoor AGM and Khan H}, journal={Curr Treat Options Oncol}}"}}, {"_id": "31926250", "pmid": 31926250, "title": "Inhibition of mTORC1/P70S6K pathway by Metformin synergistically sensitizes Acute Myeloid Leukemia to Ara-C.", "journal": "Life Sci", "authors": ["Yuan F", "Cheng C", "Xiao F", "Liu H", "Cao S", "Zhou G"], "date": "2020-02-15T00:00:00Z", "doi": "10.1016/j.lfs.2020.117276", "meta_date_publication": "2020 Feb 15", "meta_volume": "243", "meta_issue": "", "meta_pages": "117276", "score": 50248.19, "text_hl": "We finally used xenograft experiment in @SPECIES_10090 @@@mice@@@ to determine the anti-@<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@ effect of @CHEMICAL_Cytarabine @CHEMICAL_MESH:D003561 @@@Ara-C@@@/@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in vivo. ", "citations": {"NLM": "Yuan F, Cheng C, Xiao F, Liu H, Cao S, Zhou G. Inhibition of mTORC1/P70S6K pathway by Metformin synergistically sensitizes Acute Myeloid Leukemia to Ara-C. Life Sci. 2020 Feb 15;243():117276. PMID: 31926250", "BibTeX": "@article{31926250, title={Inhibition of mTORC1/P70S6K pathway by Metformin synergistically sensitizes Acute Myeloid Leukemia to Ara-C.}, author={Yuan F and Cheng C and Xiao F and Liu H and Cao S and Zhou G}, journal={Life Sci}, volume={243}, pages={117276}}"}}, {"_id": "38089917", "pmid": 38089917, "pmcid": "PMC10711185", "title": "Metformin: A potential adjunct for treatment of systemic mastocytosis", "journal": "J Allergy Clin Immunol Glob", "authors": ["Butterfield JH", "Bartemes K"], "date": "2023-11-07T00:00:00Z", "doi": "10.1016/j.jacig.2023.100186", "meta_date_publication": "2024 Feb", "meta_volume": "3", "meta_issue": "1", "meta_pages": "100186", "score": 50245.02, "text_hl": "In recent years, nonchemotherapeutic medications such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ have been repurposed for this role because of their ability to destroy CSCs from both solid @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumors@@@ and @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemias@@@ and also because of their ability to act as chemosensitizers.", "citations": {"NLM": "Butterfield JH, Bartemes K. Metformin: A potential adjunct for treatment of systemic mastocytosis J Allergy Clin Immunol Glob. 2024 Feb;3(1):100186. PMID: 38089917", "BibTeX": "@article{38089917, title={Metformin: A potential adjunct for treatment of systemic mastocytosis}, author={Butterfield JH and Bartemes K}, journal={J Allergy Clin Immunol Glob}, volume={3}, number={1}, pages={100186}}"}}, {"_id": "34659562", "pmid": 34659562, "pmcid": "PMC8518002", "title": "Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia", "journal": "J Cancer", "authors": ["Zhou FJ", "Zeng CX", "Kuang W", "Cheng C", "Liu HC", "Yan XY", "Chen XP", "Zhou G", "Cao S"], "date": "2021-09-21T00:00:00Z", "doi": "10.7150/jca.60208", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "22", "meta_pages": "6727-6739", "score": 50240.633, "text_hl": "In our previous study, we found that combination of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with @CHEMICAL_Cytarabine @CHEMICAL_MESH:D003561 @@@Cytarabine@@@ elicits strong synergistic anti-@<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@ effect in @DISEASE_Leukemia_Myeloid_Acute @DISEASE_MESH:D015470 @@@AML@@@. ", "citations": {"NLM": "Zhou FJ, Zeng CX, Kuang W, Cheng C, Liu HC, Yan XY, Chen XP, Zhou G, Cao S. Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia J Cancer. 2021;12(22):6727-6739. PMID: 34659562", "BibTeX": "@article{34659562, title={Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia}, author={Zhou FJ and Zeng CX and Kuang W and Cheng C and Liu HC and Yan XY and Chen XP and Zhou G and Cao S}, journal={J Cancer}, volume={12}, number={22}, pages={6727-6739}}"}}, {"_id": "32158929", "pmid": 32158929, "title": "How to starve cancer cells when nutrients are abundant.", "journal": "Mol Cell Oncol", "authors": ["Khan H", "Schieke SM"], "date": "2020-02-11T00:00:00Z", "doi": "10.1080/23723556.2020.1718475", "meta_date_publication": "2020", "meta_volume": "7", "meta_issue": "2", "meta_pages": "1718475", "score": 50240.633, "text_hl": "We recently described the signaling mechanism inducing a metabolic shift in response to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Phenformin @CHEMICAL_MESH:D010629 @@@phenformin@@@ in @<m>DISEASE_Leukemia</m> @DISEASE_MESH:D007938 @@@leukemia@@@ and @DISEASE_Lymphoma @DISEASE_MESH:D008223 @@@lymphoma@@@ cells. ", "citations": {"NLM": "Khan H, Schieke SM. How to starve cancer cells when nutrients are abundant. Mol Cell Oncol. 2020;7(2):1718475. PMID: 32158929", "BibTeX": "@article{32158929, title={How to starve cancer cells when nutrients are abundant.}, author={Khan H and Schieke SM}, journal={Mol Cell Oncol}, volume={7}, number={2}, pages={1718475}}"}}]}